Translating Innovation into Therapies

2017-08-15

Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.

Astia CEO, Sharon Vosmek, keynotes the ON Helix 2017 conference; speaks on Astia Angels investment thesis: <strong><em>"Putting the C in Science: Commercialisation, Community and Capital"</em></strong>

All rights reserved © 2021